Unknown

Dataset Information

Intralesional injection of rose bengal augments the efficacy of gemcitabine chemotherapy against pancreatic tumors.


ABSTRACT:

Background

Chemotherapy regimens that include the utilization of gemcitabine are the standard of care in pancreatic cancer patients. However, most patients with advanced pancreatic cancer die within the first 2 years after diagnosis, even when treated with standard of care chemotherapy. This study aims to explore combination therapies that could boost the efficacy of standard of care regimens in pancreatic cancer patients.

Methods

In this study, we used PV-10, a 10% solution of rose bengal, to induce the death of human pancreatic tumor cells in vitro. Murine in vivo studies were carried out to examine the effectiveness of the direct injection of PV-10 into syngeneic pancreatic tumors in causing lesion-specific ablation. Intralesional PV-10 treatment was combined with systemi

SUBMITTER: Innamarato P 

PROVIDER: S-EPMC8243723 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature